Cash from Operations (TTM) Chart

Historical Cash from Operations (TTM) Data

View and export this data back to 1996. Start Trial.
Date Value
June 30, 2026 292.07M
March 31, 2026 294.86M
December 31, 2025 249.32M
September 30, 2025 251.25M
June 30, 2025 287.56M
March 31, 2025 264.85M
December 31, 2024 304.72M
September 30, 2024 303.49M
June 30, 2024 298.98M
March 31, 2024 306.88M
December 31, 2023 276.43M
September 30, 2023 257.70M
June 30, 2023 254.39M
March 31, 2023 273.72M
December 31, 2022 296.31M
September 30, 2022 332.92M
June 30, 2022 325.27M
March 31, 2022 344.58M
December 31, 2021 346.31M
September 30, 2021 334.59M
June 30, 2021 352.16M
March 31, 2021 274.94M
December 31, 2020 249.54M
September 30, 2020 230.69M
June 30, 2020 205.22M
Date Value
March 31, 2020 216.37M
December 31, 2019 206.56M
September 30, 2019 182.71M
June 30, 2019 181.62M
March 31, 2019 190.51M
December 31, 2018 172.50M
September 30, 2018 165.12M
June 30, 2018 170.37M
March 31, 2018 156.38M
December 31, 2017 159.75M
September 30, 2017 162.19M
June 30, 2017 143.72M
March 31, 2017 129.23M
December 31, 2016 141.35M
September 30, 2016 138.26M
June 30, 2016 143.87M
March 31, 2016 144.65M
December 31, 2015 138.29M
September 30, 2015 135.03M
June 30, 2015 139.36M
March 31, 2015 140.06M
December 31, 2014 144.21M
September 30, 2014 140.34M
June 30, 2014 136.76M
March 31, 2014 128.91M

Cash From Operations Definition

Represents the net cash flow from the company's business operations.

Read full definition.

Cash from Operations (TTM) Range, Past 5 Years

View Cash from Operations (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Operations (TTM) Benchmarks

View Cash from Operations (TTM) Benchmarks
Start Trial
Repligen Corp. 134.86M
BioLife Solutions, Inc. 16.88M
MindWalk Holdings Corp. -8.921M
Maravai Lifesciences Holdings, Inc. -25.26M
MaxCyte, Inc. -22.98M